Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Malignant mesothelioma that arises from the pleura and is characterized by the presence of cells with epithelioid morphology. The epithelioid cells usually have eosinophilic cytoplasm, bland nuclei, and form tubulopapillary, microglandular, or sheet-like patterns.
Biomarker and diagnostic research for pleural epithelioid mesothelioma has been reported in the published literature.
2 clinical trials registered, 1 recruiting. Interventions under study include drug therapy and procedural interventions. Pipeline includes 1 PHASE2, 1 PHASE1. Research is primarily sponsored by academic and government institutions.
130 publications have been identified in PubMed for pleural epithelioid mesothelioma. Research spans Case Report / Case Series (31%), Clinical Trial Publication (17%), and Diagnostic / Biomarker (15%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 40 |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 1:12 PM UTC
Clinical study results | 22 | 17% |
Testing and diagnosis research | 20 | 15% |
Laboratory research | 19 | 15% |
Disease patterns and progression | 17 | 13% |
Research summaries | 9 | 7% |
New treatment approaches | 3 | 2% |
Zhan PL (2026). [PMID: 40588180](https://pubmed.ncbi.nlm.nih.gov/40588180/). *The Annals of thoracic surgery*. [Clinical Trial Publication]
Cummins KC (2026). [PMID: 41817934](https://pubmed.ncbi.nlm.nih.gov/41817934/). *Ann Surg Oncol*. [Epidemiology / Natural History]
Orlando G (2026). [PMID: 41954359](https://pubmed.ncbi.nlm.nih.gov/41954359/). *Pathologica*. [Diagnostic / Biomarker]
Janssens E (2026). [PMID: 41534436](https://pubmed.ncbi.nlm.nih.gov/41534436/). *Biomed Pharmacother*. [Case Report / Case Series]
An Q (2026). [PMID: 41655170](https://pubmed.ncbi.nlm.nih.gov/41655170/). *Discover oncology*. [Clinical Trial Publication]
Chauhan R (2026). [PMID: 42078591](https://pubmed.ncbi.nlm.nih.gov/42078591/). *Ann Med Surg (Lond)*. [Case Report / Case Series]
Aoe K (2026). [PMID: 41410266](https://pubmed.ncbi.nlm.nih.gov/41410266/). *Pathology international*. [Case Report / Case Series]
Avilés-Salas A (2026). [PMID: 41928138](https://pubmed.ncbi.nlm.nih.gov/41928138/). *BMC Cancer*. [Diagnostic / Biomarker]
Ibrahim WH (2026). [PMID: 41847202](https://pubmed.ncbi.nlm.nih.gov/41847202/). *Qatar Med J*. [Epidemiology / Natural History]
Lang-Lazdunski L (2026). [PMID: 39906983](https://pubmed.ncbi.nlm.nih.gov/39906983/). *Ann Surg*. [Epidemiology / Natural History]
AI-curated news mentioning pleural epithelioid mesothelioma
Updated Jul 8, 2026
A case study details a 65-year-old woman with pleural epithelioid haemangioendothelioma, presenting symptoms of chest tightness and cough. This rare vascular tumor highlights the need for awareness and further research into its clinical presentation.
A recent publication explores the role of the EZH2 gene in malignant pleural mesothelioma, highlighting its potential as a therapeutic target. The study discusses current practices and future perspectives in treatment strategies.
A study highlights a case of delayed solitary adrenal metastasis in a patient with malignant pleural mesothelioma who achieved long-term survival through immunotherapy. This case contributes to the understanding of treatment responses in rare cancers.